| Literature DB >> 30242173 |
Jian Zhang1, Jiarun Yang1, Dong Han1, Xueyan Zhao1, Jingsong Ma1, Bo Ban2, Xiongzhao Zhu3, Yanjie Yang4, Depin Cao5, Xiaohui Qiu6.
Abstract
The purpose of this study is to explore Dvl3 variants and their interaction with negative life events on MDD susceptibility in a Chinese Han population. Additionally, we also attempted to identify whether there is an association between Dvl3 variants and pro-inflammatory cytokines. A total of 1102 participants, consisting of 550 patients with MDD and 552 healthy subjects, were recruited for genotyping by TaqMan allelic discrimination assay. Pro-inflammatory cytokine mRNA levels in peripheral blood were measured by QPCR. After the assessment of negative life events by the Life Events Scale, the Dvl3 gene-environment interaction (G × E) and risk factors were evaluated using generalized multifactor dimensionality reduction method (GMDR) and logistic regression analysis, respectively. This study is the first to reveal the interaction between Dvl3 allelic variations and negative life events as well as pro-inflammatory cytokines on MDD susceptibility in a Chinese Han population.Entities:
Mesh:
Substances:
Year: 2018 PMID: 30242173 PMCID: PMC6155061 DOI: 10.1038/s41598-018-31530-2
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Demographic characteristics of participants.
| Variables | MDD (n = 550) | Control (n = 552) | χ2/t | P value |
|---|---|---|---|---|
| Age, years | 44.53 ± 13.53 | 43.19 ± 9.08 | −1.938 | 0.053 |
| Sex | 3.553 | 0.059 | ||
| Male | 165 (30.00%) | 195 (35.30%) | ||
| Female | 385 (70.00%) | 357 (64.70%) | ||
| Marital status | 5.272 | 0.261 | ||
| Single | 79 (14.40%) | 65 (11.80%) | ||
| Married | 436 (79.30%) | 459 (83.20%) | ||
| Divorced | 31 (5.60%) | 21 (3.80%) | ||
| Widowed | 4 (0.70%) | 7 (1.30%) | ||
| Negative LES score | 9.66 ± 18.37 | 2.68 ± 6.78 | −8.358 | 3.45E-16 |
Data are presented as mean ± standard deviation or number (percentage).
Genotype distribution patterns and allelic frequencies of Dvl polymorphisms among patients with MDD and control subjects.
| SNP | Sample | Genotype (%) | P | Allele (%) | P | Odds ratio (95% CI) | |||
|---|---|---|---|---|---|---|---|---|---|
| rs1969253 | CC | CA | AA | C | A | ||||
| MDD | 123 (22.4) | 302 (54.9) | 125 (22.7) | 0.056 | 548 (49.8) | 552 (50.2) | 0.055 | 1.177 | |
| Control | 162 (29.3) | 271 (49.1) | 119 (21.6) | 595 (53.9) | 509 (46.1) | (0.996–1.392) | |||
| rs1709642 | CC | CT | TT | C | T | ||||
| MDD | 107 (19.5) | 313 (56.9) | 130 (23.6) |
| 527 (47.9) | 573 (52.1) |
| 1.333 | |
| Control | 171 (31.0) | 266 (48.2) | 115 (20.8) | 608 (55.1) | 496 (44.9) | (1.127–1.576) | |||
Bold significant p-values were corrected by Bonferroni correction.
The best gene–environment interaction models obtained by GMDR.
| Locus No. | Best models | PE (%) | CV | P value |
|---|---|---|---|---|
| 2 | rs1969253, negative life events | 35.26 | 10/10 | <0.001 |
| 3 | rs1969253, rs1709642, | 34.26 | 10/10 | <0.001 |
PE, prediction error; CV, cross validation.
Interaction between Dvl3 polymorphisms and negative life events.
| Variables | MDD | Control | OR(95% CI) | P value |
|---|---|---|---|---|
|
| ||||
| and LN | 91 | 137 | 1 | |
| A− and HN | 32 | 25 |
|
|
| A+ and LN | 254 | 342 | 1.118 (0.819–1.526) | 0.481 |
| A+ and HN | 173 | 48 |
|
|
|
| ||||
| T− and LN | 84 | 146 | 1 | |
| T− and HN | 23 | 25 | 1.599 (0.854–2.992) | 0.142 |
| T+ and LN | 261 | 333 | 1.362 (0.996–1.864) | 0.053 |
| T+ and HN | 182 | 48 |
|
|
LN, low negative life events; HN, high negative life events.
Figure 1mRNA levels of pro-inflammatory cytokines (mean ± standard deviation) in peripheral blood in patients with MDD and control subjects (n = 100, each). **P < 0.01; *P < 0.05.
Figure 2mRNA levels of pro-inflammatory cytokines (mean ± standard deviation) among patients with MDD with LN and HN (n = 100, each). LN, low negative life events; HN, high negative life events (n = 100).
Figure 3mRNA levels of pro-inflammatory cytokines (mean ± standard deviation) among patients with major depressive disorder with different Dvl3 polymorphisms. A−, allele CC of rs1969253 (n = 25); A+, allele AC, AA of rs1969253 (n = 25); T-, allele CC of rs1709642 (n = 25); and T+, allele CT, TT of rs1709642 (n = 25). *P < 0.05.